30 hours ago MicroGenDx Patient Payment Portal. Login. Login using Account# and Access Code on your statement. I am a registered user. >> Go To The Portal
The laboratory utilizes molecular diagnostics and specializes in Next Generation DNA Sequencing technologies to identify pathogenic microbes within patient samples. MicroGenDX® is currently licensed to provide these services in 49 of the 50 states, with New York being the exception.
Our Billing Department is available for any questions or concerns regarding your MicroGenDX bill at at 1-855-208-0019 option #2. The Billing Department is open 8AM to 5PM CST Monday through Friday. Please call the phone number on the back of your insurance card for information on coverage of any MicroGenDX test.
Southwest Regional PCR first offered a 2-step process combining qPCR and NGS to identify microbes in 2010 under the commercial name PathoGenius. In 2017, the laboratory was purchased by Rick Martin, head of commercialization for this testing, and rebranded as Southwest Regional PCR dba MicroGenDX.
MicroGenDX laboratory has run over 500,000 next-gen DNA sequencing tests at our state-of-the-art, CAP-accredited, CLIA-licensed molecular diagnostic facility. Our advanced instrumentation, including Illumina Miseq sequencers, provides the industry’s most informative microbial diagnostics for ENT/AFB, microbiology laboratories, orthopedics, urology, wound care, podiatry, pulmonary, ExPlants, periodontal, podiatry/nail, OB-GYN, infectious disease, and other medical specialties. Our laboratory is supported by a team of molecular biologists, biochemists, bioinformaticians, computer scientists, and physicians. MicroGenDX employs over 200 passionate employees, with a leadership model that swiftly adapts to global health concerns and new technologies. We want to help as many people as possible with microbial identification of challenging infections.
Founded by an esteemed wound care doctor Randall Wolcott in 2008, and currently owned and operated by Rick Martin, a former Pfizer executive , who personally witnessed the positive clinical impact of qPCR+NGS, MicrogenDX is bringing state-of-the-art microbial DNA sequencing diagnostics to more patients every day – processing more than 100,000 samples each year.
If you have Aetna, we do not submit patient claims to your insurance because they do not cover our test. Therefore, we request that you "PAY NOW" at our discounted self-pay price of $199. You will then receive a $0 balance statement and your results will not be delayed.
If you were told that you have an insurance that is highly likely to not cover our test, we request that you "PUT YOUR CARD ON FILE". By doing so, we will only run your card after we have submitted your claim to your insurance and received your EOB (explanation of benefits) which outlines the cost you are responsible for paying.